Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Yu, Hongyan ^a   Meng, Xiangqi ^a   Wu, Jiangxue ^a   Pan, Changchuan ^c   Ying, Xiaofang ^a   Zhou, Yi ^a   Liu, Ranyi ^a   Huang, Wenlin ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c SICHUAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CRYPTOCHROME 1; CRY1 PROTEIN, HUMAN; CRYPTOCHROME; TUMOR PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; CRY1 GENE; DISEASE FREE SURVIVAL; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; ONCOGENE; OVERALL SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANTIBODY SPECIFICITY; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR CELL LINE;

ANIMALIA;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CRYPTOCHROMES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84876512352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061679     Document Type: Article

References (31)

1. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM, (2001) Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107: 855-867.
2. Reppert SM, Weaver DR, (2002) Coordination of circadian timing in mammals. Nature 418: 935-941.
3. Chu G, Yoshida K, Narahara S, Uchikawa M, Kawamura M, et al. (2011) Alterations of circadian clockworks during differentiation and apoptosis of rat ovarian cells. Chronobiol Int 28: 477-487.
4. Hayashida S, Kuramoto Y, Koyanagi S, Oishi K, Fujiki J, et al. (2010) Proxisome proliferator-activated receptor-alpha mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice. Chronobiol Int 27: 1735-1753.
5. Luo Y, Tian W, Cai L, Wang Y, Zhang J, et al. (2009) Expression profiling reveals a positive regulation by mPer2 on circadian rhythm of cytotoxicity receptors: Ly49C and Nkg2d. Chronobiol Int 26: 1514-1544.
6. Hunt T, Sassone-Corsi P, (2007) Riding tandem: circadian clocks and the cell cycle. Cell 129: 461-464.
7. Schibler U, (2007) The daily timing of gene expression and physiology in mammals. Dialogues Clin Neurosci 9: 257-272.
8. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, et al. (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93: 1563-1568.
9. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, et al. (2003) Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95: 825-828.
10. Viswanathan AN, Hankinson SE, Schernhammer ES, (2007) Night shift work and the risk of endometrial cancer. Cancer Res 67: 10618-10622.
11. Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr, et al. (2007) Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 30: 1460-1483.
12. Engelen E, Janssens RC, Yagita K, Smits VA, van der Horst GT, et al. (2013) Mammalian TIMELESS Is Involved in Period Determination and DNA Damage-Dependent Phase Advancing of the Circadian Clock. PLoS One 8: e56623.
13. Filipski E, King VM, Li X, Granda TG, Mormont MC, et al. (2002) Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94: 690-697.
14. Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, et al. (2003) A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63: 7277-7283.
15. Ozturk N, Song SH, Ozgur S, Selby CP, Morrison L, et al. (2007) Structure and function of animal cryptochromes. Cold Spring Harb Symp Quant Biol 72: 119-131.
16. Hanoun M, Eisele L, Suzuki M, Greally JM, Huttmann A, et al. (2012) Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 7: e34347.
17. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, et al. (2010) Colorectal cancer. Lancet 375: 1030-1047.
18. Singh R, Lillard JW Jr, Singh S, (2011) Chemokines: key players in cancer progression and metastasis. Front Biosci (Schol Ed) 3: 1569-1582.
19. Wang H, Wu J, Meng X, Ying X, Zuo Y, et al. (2011) MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32: 1033-1042.
20. Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, et al. (2011) Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 25: 1439-1446.
21. Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, et al. (2011) Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int 28: 841-851.
22. Tokunaga H, Takebayashi Y, Utsunomiya H, Akahira J, Higashimoto M, et al. (2008) Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstet Gynecol Scand 87: 1060-1070.
23. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, et al. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259.
24. Gauger MA, Sancar A, (2005) Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 65: 6828-6834.
25. Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, et al. (2012) Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A 109: 12662-12667.
26. Chen Y, Wang Y, Yu H, Wang F, Xu W, (2005) The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells. Exp Biol Med (Maywood) 230: 731-741.
27. Wang Y, Chen Y, Chen M, Xu W, (2006) AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity. Oncol Rep 16: 755-761.
28. Kjoller L, Hall A, (1999) Signaling to Rho GTPases. Exp Cell Res 253: 166-179.
29. Sahai E, Marshall CJ, (2002) RHO-GTPases and cancer. Nat Rev Cancer 2: 133-142.
30. Takai Y, Sasaki T, Matozaki T, (2001) Small GTP-binding proteins. Physiol Rev 81: 153-208.
31. Narumiya S, (1996) The small GTPase Rho: cellular functions and signal transduction. J Biochem 120: 215-228.